CRSP icon

CRISPR Therapeutics
CRSP

Overview Fund Activity

403 hedge funds and large institutions have $2.5B invested in CRISPR Therapeutics in 2023 Q3 according to their latest regulatory filings, with 45 funds opening new positions, 154 increasing their positions, 100 reducing their positions, and 53 closing their positions.

Holders
403
Holders Change
-12
Holders Change %
-2.89%
% of All Funds
6.43%
Holding in Top 10
3
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-25%
% of All Funds
0.05%
New
45
Increased
154
Reduced
100
Closed
53
Calls
$80.5M
Puts
$91.5M
Net Calls
-$11M
Net Calls Change
-$41M

Top Buyers

1
Westfield Capital Management
1
Westfield Capital Management
Massachusetts
$13.5M
2
State Street
2
State Street
Massachusetts
$85.6M
3
Baillie Gifford & Co
3
Baillie Gifford & Co
United Kingdom
$20M
4
IHAM
4
Integral Health Asset Management
New York
$12.5M
5
Dimensional Fund Advisors
5
Dimensional Fund Advisors
Texas
$39.9M

Top Sellers

1
Marshall Wace
1
Marshall Wace
United Kingdom
$6.17M
2
VCM
2
Valiant Capital Management
California
$0
3
Two Sigma Investments
3
Two Sigma Investments
New York
$9.98M
4
AIM
4
ARK Investment Management
Florida
$325M
5
Man Group
5
Man Group
United Kingdom
$8.08M
Name Market Value Shares Shares
Change 		Shares
Change %
AIM
1
ARK Investment Management
Florida
$325M 7,163,118 -175,329 -2%
Capital International Investors
2
Capital International Investors
California
$276M 6,085,512 +15,789 +0.3%
T. Rowe Price Investment Management
3
T. Rowe Price Investment Management
Maryland
$166M 3,651,833 +5,251 +0.1%
Sumitomo Mitsui Trust Group
4
Sumitomo Mitsui Trust Group
Japan
$157M 3,465,470 -67,887 -2%
NAMA
5
Nikko Asset Management Americas
New York
$157M 3,465,470 -67,887 -2%
BlackRock
6
BlackRock
New York
$123M 2,713,210 -5,365 -0.2%
Fidelity Investments
7
Fidelity Investments
Massachusetts
$93.4M 2,057,414 -33,759 -2%
State Street
8
State Street
Massachusetts
$85.6M 1,884,973 +252,500 +15%
NMC
9
NEA Management Company
Maryland
$72.1M 1,587,854 – –
Vanguard Group
10
Vanguard Group
Pennsylvania
$69.8M 1,538,725 +7,635 +0.5%
Loomis, Sayles & Company
11
Loomis, Sayles & Company
Massachusetts
$49.8M 1,096,354 -51,575 -4%
BG
12
Bellevue Group
Switzerland
$40.8M 898,400 -900 -0.1%
Dimensional Fund Advisors
13
Dimensional Fund Advisors
Texas
$39.9M 879,801 +168,530 +24%
CS
14
Credit Suisse
Switzerland
$39.6M 872,931 -48,725 -5%
T. Rowe Price Associates
15
T. Rowe Price Associates
Maryland
$39.5M 869,637 -12,738 -1%
Geode Capital Management
16
Geode Capital Management
Massachusetts
$38.6M 849,938 +15,331 +2%
Bank of America
17
Bank of America
North Carolina
$30.9M 679,699 -74,858 -10%
Charles Schwab
18
Charles Schwab
California
$29M 637,938 -8,773 -1%
AC
19
Armistice Capital
New York
$27.2M 600,012 +100,012 +20%
Norges Bank
20
Norges Bank
Norway
$26.6M 586,300 +9,267 +2%
JPMorgan Chase & Co
21
JPMorgan Chase & Co
New York
$23.6M 520,429 -30,966 -6%
Barclays
22
Barclays
United Kingdom
$23.2M 510,832 +137,629 +37%
Federated Hermes
23
Federated Hermes
Pennsylvania
$23.1M 508,100 -658 -0.1%
VVM
24
Versant Venture Management
California
$22.6M 498,558 – –
Baillie Gifford & Co
25
Baillie Gifford & Co
United Kingdom
$20M 441,063 +197,469 +81%
1
2 3 4 5